Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
30.76
+0.13 (0.41%)
Nov 21, 2024, 10:54 AM EST - Market open

Akero Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
56
Market Cap
2.15B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Astrana Health 1.72B
Addus HomeCare 1.13B
Omnicell 1.06B
Evotec SE 866.67M
Amphastar Pharmaceuticals 723.55M
Mirum Pharmaceuticals 307.03M
GeneDx Holdings 267.23M
Ligand Pharmaceuticals 152.42M
Revenue Rankings